Guangzhou Lays Out Biopharma Welcome Mat In Investment Push
This article was originally published in PharmAsia News
Guangzhou is planning to deepen investment in the biopharmaceutical industry and to formulate preferential policies and incentives to encourage tie-ups with multinational pharma firms. The provincial capital aims to develop the industry as a pillar sector that will contribute 15% of its GDP by 2025.
Register for our free email digests: